Skip to main content
Contact Us
Subscribe
e-Edition
Sign Up
Log In
Dashboard
Logout
My Account
Dashboard
Profile
Saved items
Logout
54°
Site search
Search
Menu
Subscribe
Home
News
Local News
Sports
Obituaries
Photos
e-Edition
Classifieds
Real Estate
Property For Rent
Cars & Vehicles
Jobs
Items For Sale
Pets
Auctions, Estate & Garage Sales
Services
Community
Personals
Place An Ad
Explore the Sheyenne
Best of 2023
Archives
Recent Quotes
View Full List
My Watchlist
Create Watchlist
Indicators
DJI
Nasdaq Composite
SPX
Gold
Crude Oil
Markets
Stocks
ETFs
Tools
Overview
News
Currencies
International
Treasuries
Nanoviricides Inc
(NY:
NNVC
)
1.140
+0.020 (+1.79%)
Streaming Delayed Price
Updated: 1:36 PM EDT, Apr 23, 2024
Add to My Watchlist
Quote
Overview
Detailed Quote
Charting
Historical Prices
News
All News
News Headlines
Press Releases
Research
Quarterly Reports
Insider Filings
Other Filings
Headline News about Nanoviricides Inc
< Previous
1
2
3
Next >
A New COVID-19 Variant Is Rapidly Spreading Around The Globe, Other Pandemic Threats Exist – What Are The Choices For Treatment?
January 31, 2024
Colds, flu and RSV aren't the only viral illnesses people have to worry about this winter. A new variant of COVID-19 is rapidly spreading, reminding the world of just how dangerous this virus is.
Via
Benzinga
Exposures
COVID-19
NanoViricides, Inc. (NNVC) To Unveil Cutting-Edge Antiviral Breakthroughs At Biotech Showcase™ 2024
January 08, 2024
NanoViricides, Inc. (NYSE American: NNVC) recently announced that it is presenting at Biotech Showcase™ 2024. Event Information: Event NanoViricides Presentation at the Biotech Showcase, San Fransisco
Via
Benzinga
Is This Ticker That InvestorsObserver Expects To Soar By More Than 350% Next Year On Your Watchlist?
December 01, 2023
--News Direct--
Via
News Direct
Topics
Death
Exposures
COVID-19
Death
Multi-Billion Dollar Treatment Market For Lung Infection That Causes Over 200,000 Hospitalizations Annually With Elderly, Young At Most Risk Has Game-Changing New Entrant
October 02, 2023
Read the latest report on NanoViricides here
Via
Benzinga
Multi-Billion Dollar Treatment Market For Lung Infection That Causes Over 200,000 Hospitalizations Annually With Elderly, Young At Most Risk Has Game-Changing New Entrant
September 26, 2023
Read the latest report on NanoViricides here
Via
Benzinga
Short Volatility Alert: NanoViricides, Inc.
August 05, 2022
On Thursday, shares of NanoViricides, Inc. (NYSE: NNVC) experienced volatile short activity. After the activity, the stock price went up +48.37% to $3.65. The overall sentiment for NNVC has been...
Via
Benzinga
12 Health Care Stocks Moving In Tuesday's Intraday Session
August 22, 2023
Via
Benzinga
SARS-CoV-2 Is Not Done Yet — Could This New Drug In Clinical Trials Be The Safest Option For Treating COVID-19?
July 18, 2023
Read the latest report on NanoViricides here.
Via
Benzinga
12 Health Care Stocks Moving In Tuesday's Intraday Session
July 11, 2023
Via
Benzinga
Why Are NanoViricides Shares Gaining Today
July 11, 2023
NanoViricides Inc (NYSE: NNVC) shares are trading higher after the company reported preclinical data from an antiviral clinical drug candidate for
Via
Benzinga
Novel Nanomedicine Platform With Pipeline Of Antivirals Goes To Human Trials – What Other Viruses Could This COVID Treatment Target?
July 11, 2023
Novel Nanomedicine Platform With Pipeline Of Antivirals Goes To Human Trials – What Other Viruses Could This COVID Treatment Target?
Via
News Direct
Exposures
COVID-19
Why Better Therapeutics Are Trading Higher By 51%; Here Are 20 Stocks Moving Premarket
July 11, 2023
Gainers CytoMed Therapeutics Limited (NASDAQ: GDTC) shares surged 109.2% to $7.30 in pre-market trading after gaining 9% on Monday.
Via
Benzinga
Novel Nanomedicine Platform With Pipeline Of Antivirals Goes To Human Trials – What Other Viruses Could This COVID Treatment Target?
July 10, 2023
Read the latest report on NanoViricides here.
Via
Benzinga
NanoViricides Inc. (NYSE American: NNVC) Begins Long-Awaited Clinical Trials For Its Anti-Viral Nanomedicine NV-CoV-2, Oral, Amid Continuing Need For COVID Treatment
July 06, 2023
NanoViricides Inc. (NYSE American: NNVC) Begins Long-Awaited Clinical Trials For Its Anti-Viral Nanomedicine NV-CoV-2, Oral, Amid Continuing Need For COVID Treatment
Via
News Direct
Exposures
COVID-19
NanoViricides Inc. (NYSE American: NNVC) Begins Long-Awaited Clinical Trials For Its Anti-Viral Nanomedicine NV-CoV-2, Oral, Amid Continuing Need For COVID Treatment
July 05, 2023
Read the latest report on NanoViricides here.
Via
Benzinga
The 7 Most Promising Penny Stocks to Buy in June
June 07, 2023
These top penny stocks for June look to have legitimate catalysts that can certainly send share prices higher.
Via
InvestorPlace
12 Health Care Stocks Moving In Friday's Pre-Market Session
June 02, 2023
Via
Benzinga
12 Health Care Stocks Moving In Thursday's Intraday Session
June 01, 2023
Via
Benzinga
12 Health Care Stocks Moving In Friday's Intraday Session
April 07, 2023
Via
Benzinga
12 Health Care Stocks Moving In Thursday's Intraday Session
April 06, 2023
Via
Benzinga
COVID Remains A Global Threat – NanoViricides Set To Begin Clinical Trials For Pan-Coronavirus Drug To Help Defeat COVID Once And For All
March 31, 2023
COVID Remains A Global Threat – NanoViricides Set To Begin Clinical Trials For Pan-Coronavirus Drug To Help Defeat COVID Once And For All
Via
News Direct
Exposures
COVID-19
A Company With Solutions Against Emerging COVID Variants And Other Viral Infections To Combat Future Pandemic Threats
March 20, 2023
A Company With Solutions Against Emerging COVID Variants And Other Viral Infections To Combat Future Pandemic Threats
Via
News Direct
Topics
Death
Economy
Exposures
COVID-19
Death
Economy
With Nearly 20,000 Americans Still Hospitalized, COVID Remains A Threat – NanoViricides Gets Ready To Begin Clinical Trials For The World To Defeat It
March 08, 2023
With Nearly 20,000 Americans Still Hospitalized, COVID Remains A Threat – NanoViricides Gets Ready To Begin Clinical Trials For The World To Defeat It
Via
News Direct
Topics
Death
Exposures
COVID-19
Death
With Nearly 20,000 Americans Still Hospitalized, COVID Remains A Threat – NanoViricides Gets Ready To Begin Clinical Trials For The World To Defeat It, And To Prepare For Battling Against The Next Likely Coronavirus Pandemic
March 08, 2023
Read the latest report on NanoViricides, Inc (NYSE: NNVC) here.
Via
Benzinga
uniQure To Rally Around 162%? Here Are 10 Other Analyst Forecasts For Tuesday
February 28, 2023
UBS cut the price target for Honeywell International Inc. (NASDAQ: HON) from $193 to $185. UBS analyst Chris Snyder maintained a Sell rating. Honeywell shares fell 0.2% to $191.99 in pre-market...
Via
Benzinga
7 Speculative Penny Stocks Under $3 That Deserve Your Attention in Nov.
October 28, 2022
While penny stocks are highly speculative and risky, you may still want to consider these seven opportunities.
Via
InvestorPlace
This Company Is Looking For A Monkeypox Drug As City Investigates Deaths
October 27, 2022
By David Willey, Benzinga
Via
News Direct
Topics
Death
Exposures
COVID-19
Death
This Company Is Looking For A Monkeypox Drug As City Investigates Deaths
October 27, 2022
New York City is investigating the cause of death for two people who died after contracting monkeypox.
Via
Benzinga
NanoViricides Reports Its Novel Monkeypox Antiviral Could Reach Clinical Status Rapidly
September 19, 2022
By Rachael Green, Benzinga
Via
News Direct
Monkeypox Is Popping Up In Places It Shouldn't But NanoViricides Says It May Have A Solution
August 10, 2022
More than 30,000 confirmed or suspected cases of monkeypox have been reported across 93 countries in the world. While those numbers are still small scientists are now concerned that this sudden and...
Via
Benzinga
< Previous
1
2
3
Next >
Data & News supplied by
www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy
and
Terms and Conditions
.